Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript April 8, 2026 Evotec SE reports earnings inline with expectations. Reported EPS is $0.2098 EPS, expectations were $0.2098. Operator: Ladies and ...
Dieter Weinand is proposed to succeed Prof. Dr. Iris Löw-Friedrich, whose term as Chairwoman of the Supervisory Board will conclude at the end of the 2026 Annual General Meeting, in line with the ...
Following an executive order from the Trump administration that promotes production of glyphosate, some Democrats have ...
A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the ...
Strengthens Supervisory Board leadership to support Evotec's transformation, with a focus on commercial execution, strategic partnerships and profitabilityIndustry veteran brings more than 30 years of ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results